Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 487

1.

A population-based audit of surgical practice and outcomes of oncoplastic breast conservations in Scotland - An analysis of 589 patients.

Romics L, Macaskill EJ, Fernandez T, Simpson L, Morrow E, Pitsinis V, Tovey S, Barber M, Masannat Y, Stallard S, Weiler-Mithoff E, Malyon A, Mansell J, Campbell EJ, Doughty J, Dixon JM.

Eur J Surg Oncol. 2018 Jul;44(7):939-944. doi: 10.1016/j.ejso.2018.04.004. Epub 2018 Apr 13.

PMID:
29705287
2.

Conformational Change-Induced Fluorescence of Bovine Serum Albumin-Gold Complexes.

Dixon JM, Egusa S.

J Am Chem Soc. 2018 Feb 14;140(6):2265-2271. doi: 10.1021/jacs.7b11712. Epub 2018 Feb 2.

PMID:
29361222
3.

Autologous breast reconstruction using the immediately lipofilled extended latissimus dorsi flap.

Johns N, Fairbairn N, Trail M, Ewing A, Yong L, Raine C, Dixon JM.

J Plast Reconstr Aesthet Surg. 2018 Feb;71(2):201-208. doi: 10.1016/j.bjps.2017.10.015. Epub 2017 Nov 24.

PMID:
29239797
4.

Pre-operative Endocrine Therapy.

Arthur LM, Turnbull AK, Khan LR, Dixon JM.

Curr Breast Cancer Rep. 2017;9(4):202-209. doi: 10.1007/s12609-017-0255-6. Epub 2017 Oct 27. Review.

5.

Margin width and local recurrence after breast conserving surgery for ductal carcinoma in situ.

Ekatah GE, Turnbull AK, Arthur LM, Thomas J, Dodds C, Dixon JM.

Eur J Surg Oncol. 2017 Nov;43(11):2029-2035. doi: 10.1016/j.ejso.2017.08.003. Epub 2017 Sep 4.

PMID:
28917445
6.

European interpretation of North American post mastectomy radiotherapy guideline update.

Kunkler IH, Dixon JM, Maclennan M, Russell NS.

Eur J Surg Oncol. 2017 Oct;43(10):1805-1807. doi: 10.1016/j.ejso.2017.04.004. Epub 2017 May 10. No abstract available.

PMID:
28847645
7.

Response Letter.

Brezezinska M, Williams LJ, Thomas J, Dixon JM.

Breast Cancer Res Treat. 2017 Oct;165(3):783-784. doi: 10.1007/s10549-017-4368-4. No abstract available.

PMID:
28698972
8.

Whither surgical quality assurance of breast cancer surgery (surgical margins and local recurrence) after paterson.

Bundred NJ, Thomas J, Dixon JMJ.

Breast Cancer Res Treat. 2017 Oct;165(3):473-475. doi: 10.1007/s10549-017-4369-3. Epub 2017 Jul 5.

PMID:
28681172
9.

Neoadjuvant Therapy in Early Breast Cancer: Treatment Considerations and Common Debates in Practice.

Cain H, Macpherson IR, Beresford M, Pinder SE, Pong J, Dixon JM.

Clin Oncol (R Coll Radiol). 2017 Oct;29(10):642-652. doi: 10.1016/j.clon.2017.06.003. Epub 2017 Jun 29. Review.

10.

Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast.

Martínez-Pérez C, Turnbull AK, Ekatah GE, Arthur LM, Sims AH, Thomas JS, Dixon JM.

Cancer Treat Rev. 2017 Apr;55:163-172. doi: 10.1016/j.ctrv.2017.03.009. Epub 2017 Mar 31. Review.

PMID:
28402908
11.

Immediate lipofilling in breast conserving surgery.

Khan LR, Raine CR, Dixon JM.

Eur J Surg Oncol. 2017 Aug;43(8):1402-1408. doi: 10.1016/j.ejso.2017.03.014. Epub 2017 Mar 27.

PMID:
28390738
12.

Reply to letter to editor: "Intra-operative assessment of excised breast tumour Margins using Clear Edge imaging device".

Dixon JM.

Eur J Surg Oncol. 2017 Aug;43(8):1604-1605. doi: 10.1016/j.ejso.2017.02.011. Epub 2017 Feb 27. No abstract available.

PMID:
28318685
13.

The State of Emergency Medical Services (EMS) Systems in Africa.

Mould-Millman NK, Dixon JM, Sefa N, Yancey A, Hollong BG, Hagahmed M, Ginde AA, Wallis LA.

Prehosp Disaster Med. 2017 Jun;32(3):273-283. doi: 10.1017/S1049023X17000061. Epub 2017 Feb 23.

PMID:
28228178
14.

A PAM50-Based Chemoendocrine Score for Hormone Receptor-Positive Breast Cancer with an Intermediate Risk of Relapse.

Prat A, Lluch A, Turnbull AK, Dunbier AK, Calvo L, Albanell J, de la Haba-Rodríguez J, Arcusa A, Chacón JI, Sánchez-Rovira P, Plazaola A, Muñoz M, Paré L, Parker JS, Ribelles N, Jimenez B, Bin Aiderus AA, Caballero R, Adamo B, Dowsett M, Carrasco E, Martín M, Dixon JM, Perou CM, Alba E.

Clin Cancer Res. 2017 Jun 15;23(12):3035-3044. doi: 10.1158/1078-0432.CCR-16-2092. Epub 2016 Nov 30.

15.
16.

Should patients with early breast cancer still be offered the choice of breast conserving surgery or mastectomy?

Johns N, Dixon JM.

Eur J Surg Oncol. 2016 Nov;42(11):1636-1641. doi: 10.1016/j.ejso.2016.08.016. Epub 2016 Aug 31. Review.

PMID:
27665053
17.

Contemporary social media engagement by breast surgeons.

Ekatah GE, Walker SG, McDonald JJ, Dixon JM, Brady RRW.

Breast. 2016 Dec;30:172-174. doi: 10.1016/j.breast.2016.09.010. Epub 2016 Oct 14.

PMID:
27750107
18.

Intra-operative assessment of excised breast tumour margins using ClearEdge imaging device.

Dixon JM, Renshaw L, Young O, Kulkarni D, Saleem T, Sarfaty M, Sreenivasan R, Kusnick C, Thomas J, Williams LJ.

Eur J Surg Oncol. 2016 Dec;42(12):1834-1840. doi: 10.1016/j.ejso.2016.07.141. Epub 2016 Aug 10.

PMID:
27591938
19.

Sentinel Lymph Node Biopsy in Breast Cancer Surgery.

Dixon JM.

Ann Surg Oncol. 2016 Oct;23(11):3426-3428. doi: 10.1245/s10434-016-5434-6. Epub 2016 Jul 22. No abstract available.

PMID:
27448117
20.

Tumour sampling method can significantly influence gene expression profiles derived from neoadjuvant window studies.

Pearce DA, Arthur LM, Turnbull AK, Renshaw L, Sabine VS, Thomas JS, Bartlett JM, Dixon JM, Sims AH.

Sci Rep. 2016 Jul 7;6:29434. doi: 10.1038/srep29434.

21.

Treatment with aromatase inhibitors stimulates the expression of epidermal growth factor receptor-1 and neuregulin 1 in ER positive/HER-2/neu non-amplified primary breast cancers.

Flågeng MH, Larionov A, Geisler J, Knappskog S, Prestvik WS, Bjørkøy G, Lilleng PK, Dixon JM, Miller WR, Lønning PE, Mellgren G.

J Steroid Biochem Mol Biol. 2017 Jan;165(Pt B):228-235. doi: 10.1016/j.jsbmb.2016.06.011. Epub 2016 Jun 22.

PMID:
27343990
22.

Association between underestimation of tumour size by imaging and incomplete excision in breast-conserving surgery for breast cancer.

Dixon JM, Newlands C, Dodds C, Thomas J, Williams LJ, Kunkler IH, Bing A, Macaskill EJ.

Br J Surg. 2016 Jun;103(7):830-8. doi: 10.1002/bjs.10126.

PMID:
27171027
23.

Importance of margin width in breast-conserving treatment of early breast cancer.

Bodilsen A, Bjerre K, Offersen BV, Vahl P, Amby N, Dixon JM, Ejlertsen B, Overgaard J, Christiansen P.

J Surg Oncol. 2016 May;113(6):609-15. doi: 10.1002/jso.24224. Epub 2016 Mar 16.

PMID:
26991020
24.

A study of margin width and local recurrence in breast conserving therapy for invasive breast cancer.

Dixon JM, Thomas J, Kerr GR, Williams LJ, Dodds C, Kunkler IH, Macaskill EJ.

Eur J Surg Oncol. 2016 May;42(5):657-64. doi: 10.1016/j.ejso.2016.02.008. Epub 2016 Feb 18.

PMID:
26944365
25.

A Rare Presentation of Chest Wall Chondrosarcoma as a Breast Mass.

Vaughan EM, Loh SF, Beesley M, West CC, Dixon JM.

Breast J. 2016 Mar-Apr;22(2):235-7. doi: 10.1111/tbj.12553. Epub 2016 Feb 4. No abstract available.

PMID:
26843126
26.

Pooled long-term outcomes from two randomized trials of axillary node sampling with axillary radiotherapy versus axillary node clearance in patients with operable node-positive breast cancer.

Bing AU, Kerr GR, Jack W, Chetty U, Williams LJ, Rodger A, Dixon JM.

Br J Surg. 2016 Jan;103(1):81-7. doi: 10.1002/bjs.9952.

PMID:
26768099
27.

Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors.

Varešlija D, McBryan J, Fagan A, Redmond AM, Hao Y, Sims AH, Turnbull A, Dixon JM, Ó Gaora P, Hudson L, Purcell S, Hill AD, Young LS.

Clin Cancer Res. 2016 Jun 1;22(11):2765-77. doi: 10.1158/1078-0432.CCR-15-1583. Epub 2016 Jan 13.

28.

Endocrine resistance in breast cancer--An overview and update.

Clarke R, Tyson JJ, Dixon JM.

Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3:220-34. doi: 10.1016/j.mce.2015.09.035. Epub 2015 Oct 9. Review.

29.

Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.

Ward C, Meehan J, Mullen P, Supuran C, Dixon JM, Thomas JS, Winum JY, Lambin P, Dubois L, Pavathaneni NK, Jarman EJ, Renshaw L, Um IH, Kay C, Harrison DJ, Kunkler IH, Langdon SP.

Oncotarget. 2015 Sep 22;6(28):24856-70. doi: 10.18632/oncotarget.4498.

30.

Actinomyces Species Isolated from Breast Infections.

Bing AU, Loh SF, Morris T, Hughes H, Dixon JM, Helgason KO.

J Clin Microbiol. 2015 Oct;53(10):3247-55. doi: 10.1128/JCM.01030-15. Epub 2015 Jul 29.

31.

Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group.

Provenzano E, Bossuyt V, Viale G, Cameron D, Badve S, Denkert C, MacGrogan G, Penault-Llorca F, Boughey J, Curigliano G, Dixon JM, Esserman L, Fastner G, Kuehn T, Peintinger F, von Minckwitz G, White J, Yang W, Symmans WF; Residual Disease Characterization Working Group of the Breast International Group-North American Breast Cancer Group Collaboration.

Mod Pathol. 2015 Sep;28(9):1185-201. doi: 10.1038/modpathol.2015.74. Epub 2015 Jul 24.

32.

Intra-operative digital specimen radiology reduces re-operation rates in therapeutic mammaplasty for breast cancer.

Majdak-Paredes EJ, Schaverien MV, Szychta P, Raine C, Dixon JM.

Breast. 2015 Oct;24(5):556-9. doi: 10.1016/j.breast.2015.04.007. Epub 2015 Jun 26.

PMID:
26119619
33.

Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer.

Turnbull AK, Arthur LM, Renshaw L, Larionov AA, Kay C, Dunbier AK, Thomas JS, Dowsett M, Sims AH, Dixon JM.

J Clin Oncol. 2015 Jul 10;33(20):2270-8. doi: 10.1200/JCO.2014.57.8963. Epub 2015 Jun 1.

PMID:
26033813
34.

Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration.

Bossuyt V, Provenzano E, Symmans WF, Boughey JC, Coles C, Curigliano G, Dixon JM, Esserman LJ, Fastner G, Kuehn T, Peintinger F, von Minckwitz G, White J, Yang W, Badve S, Denkert C, MacGrogan G, Penault-Llorca F, Viale G, Cameron D; Breast International Group-North American Breast Cancer Group (BIG-NABCG) collaboration.

Ann Oncol. 2015 Jul;26(7):1280-91. doi: 10.1093/annonc/mdv161. Epub 2015 May 27. Review.

35.

Meta-analysis of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ.

Fancellu A, Turner RM, Dixon JM, Pinna A, Cottu P, Houssami N.

Br J Surg. 2015 Jul;102(8):883-93. doi: 10.1002/bjs.9797. Epub 2015 Apr 28. Review.

PMID:
25919321
36.

Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer.

López-Knowles E, Wilkerson PM, Ribas R, Anderson H, Mackay A, Ghazoui Z, Rani A, Osin P, Nerurkar A, Renshaw L, Larionov A, Miller WR, Dixon JM, Reis-Filho JS, Dunbier AK, Martin LA, Dowsett M.

Breast Cancer Res. 2015 Mar 11;17:35. doi: 10.1186/s13058-015-0532-0.

37.

Correction to Lancet Oncol 2015; 16: 266.

Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM; PRIME II investigators.

Lancet Oncol. 2015 Mar;16(3):e105. doi: 10.1016/S1470-2045(15)70094-X. No abstract available.

PMID:
25752559
38.

Authors' reply to Rayter.

Dixon JM, Rutgers E, Hunt KK.

BMJ. 2015 Feb 11;350:h714. doi: 10.1136/bmj.h714. No abstract available.

39.

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.

Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM; PRIME II investigators.

Lancet Oncol. 2015 Mar;16(3):266-73. doi: 10.1016/S1470-2045(14)71221-5. Epub 2015 Jan 28. Erratum in: Lancet Oncol. 2015 Mar;16(3):e105.

PMID:
25637340
40.

Intraoperative assessment of axillary lymph nodes in patients with breast cancer.

Dixon JM, Rutgers E, Hunt KK.

BMJ. 2014 Nov 25;349:g6803. doi: 10.1136/bmj.g6803. No abstract available.

PMID:
25425017
41.

Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research.

Moossdorff M, van Roozendaal LM, Strobbe LJ, Aebi S, Cameron DA, Dixon JM, Giuliano AE, Haffty BG, Hickey BE, Hudis CA, Klimberg VS, Koczwara B, Kühn T, Lippman ME, Lucci A, Piccart M, Smith BD, Tjan-Heijnen VC, van de Velde CJ, Van Zee KJ, Vermorken JB, Viale G, Voogd AC, Wapnir IL, White JR, Smidt ML.

J Natl Cancer Inst. 2014 Nov 7;106(12). pii: dju288. doi: 10.1093/jnci/dju288. Print 2014 Dec.

42.

Outcome of the use of acellular-dermal matrix to assist implant-based breast reconstruction in a single centre.

Barber MD, Williams L, Anderson ED, Neades GT, Raine C, Young O, Kulkarni D, Young I, Dixon JM.

Eur J Surg Oncol. 2015 Jan;41(1):100-5. doi: 10.1016/j.ejso.2014.08.475. Epub 2014 Sep 6.

PMID:
25238954
43.

Changes in PIK3CA mutation status are not associated with recurrence, metastatic disease or progression in endocrine-treated breast cancer.

Arthur LM, Turnbull AK, Renshaw L, Keys J, Thomas JS, Wilson TR, Lackner MR, Sims AH, Dixon JM.

Breast Cancer Res Treat. 2014 Aug;147(1):211-9. doi: 10.1007/s10549-014-3080-x. Epub 2014 Aug 9.

PMID:
25104442
44.

Molecular changes in lobular breast cancers in response to endocrine therapy.

Arthur LM, Turnbull AK, Webber VL, Larionov AA, Renshaw L, Kay C, Thomas JS, Dixon JM, Sims AH.

Cancer Res. 2014 Oct 1;74(19):5371-6. doi: 10.1158/0008-5472.CAN-14-0620. Epub 2014 Aug 6.

45.

In regard to Moran et al.

Dixon JM, Thomas J.

Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1139. doi: 10.1016/j.ijrobp.2014.04.031. Epub 2014 Jul 8. No abstract available.

PMID:
25035220
46.

High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients.

Sokolenko AP, Bulanova DR, Iyevleva AG, Aleksakhina SN, Preobrazhenskaya EV, Ivantsov AO, Kuligina ESh, Mitiushkina NV, Suspitsin EN, Yanus GA, Zaitseva OA, Yatsuk OS, Togo AV, Kota P, Dixon JM, Larionov AA, Kuznetsov SG, Imyanitov EN.

Int J Cancer. 2014 May 15;134(10):2352-8. doi: 10.1002/ijc.28569. Epub 2014 Jan 27.

47.

Carcinoma in situ.

Bundred N, Dixon JM.

BMJ. 2013 Dec 23;347:f3289. doi: 10.1136/bmj.f3289. Review. No abstract available.

PMID:
24365752
48.

Breast infection.

Dixon JM.

BMJ. 2013 Dec 16;347:f3291. doi: 10.1136/bmj.f3291. Review. No abstract available.

PMID:
24344239
49.

Mastalgia.

Iddon J, Dixon JM.

BMJ. 2013 Dec 13;347:f3288. doi: 10.1136/bmj.f3288. Review. No abstract available.

PMID:
24336097
50.

A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancer.

Robertson JF, Dixon JM, Sibbering DM, Jahan A, Ellis IO, Channon E, Hyman-Taylor P, Nicholson RI, Gee JM.

Breast Cancer Res. 2013 Mar 5;15(2):R18. doi: 10.1186/bcr3393.

Supplemental Content

Loading ...
Support Center